Kolkata-based Navam Capital is one of India’s few venture firms built specifically around deep technology. Founded by Rajeev Mantri — previously an investor at New York-based Lux Capital, where he focused on climate tech, biotech and advanced materials, and co-founder of biopharma venture Vyome Therapeutics — the firm backs engineering-driven founders who are turning breakthrough science into companies.
Its pitch to founders is patience: long-term capital for ventures translating inventions into products, from a team blending science, technology, business operations and investment experience.
Investment thesis
Navam invests in ventures pursuing breakthrough science and engineering-led innovation. Its belief is that technological change redraws firm boundaries and value chains, creating space for new champions — and it wants to back those ventures. The focus is intellectual-property-led deep technology built in India for global markets, often emerging from institutions such as the Indian Institute of Science and the IITs.
Fund size and cheque size
Navam’s maiden vehicle, Navam Venture Fund-I, is an early-stage Category II alternative investment fund (AIF) that closed above target at over ₹315 crore (about $35 million), after an initial target of ₹250 crore and a green shoe option. Its first close, in March 2024, was ₹50 crore. Limited partners include technology founders, industrial groups, business operators and family offices, and the fund is largely backed by domestic rupee capital.
The fund typically writes first cheques of ₹5–8 crore at the seed and pre-Series A stages, reserving capital for follow-on rounds, and selectively participates in Series A and Series B rounds. It plans to back 15–16 companies in all and had already invested in eight at the time of its final close.
Sectors and stages
Navam’s mandate spans advanced computing, semiconductors, robotics, drones, space technology, industrial automation, enterprise AI, climate tech and materials science — more than 10 domains. Sourcing runs through founder networks, academia, research institutions and industrial labs, with technical diligence supported by domain experts.
Notable portfolio
The portfolio includes Agnikul Cosmos, Ather Energy, drone companies Aereo, Vayudh and TechEagle, earth-observation startup GalaxEye, fabless semiconductor firm Morphing Machines, power-delivery startup C2i Semiconductors, cancer therapeutics company Alyssum Therapeutics, manufacturing-AI startup Frinks AI, precision-agriculture platform Fasal and warehouse robotics company Unbox Robotics. Aereo raised a $15 million Series B, and Ather listed in May 2025 — Navam joined Ather at its January 2022 Series E, so it was a later-stage backer there.
Team and partners
Rajeev Mantri is Founder and Managing Partner, Anjan Ray is Investment Partner, and Shiladitya Sengupta and Tarun Mehta are venture advisors. The firm also publishes Tricorder, a newsletter on technology, investing and venture capital.
Programmes, credits and perks
Navam runs no formal accelerator and publishes no credits and perks programme. Support is hands-on venture assistance: technical diligence, help turning lab breakthroughs into manufacturable products, and introductions through its industrial network. Any credits or perks are not publicly disclosed.
How to apply for funding
Founders can reach Navam through the “Get in Touch” route on navamcapital.com. Given its sourcing model, a warm introduction through a founder, researcher or industrial contact is likely to travel further than a cold email. Come prepared to defend the IP: what is genuinely novel, and why the product can be manufactured and sold at scale.
Why it matters for founders
Navam is a rare India-based option for founders whose moat is science rather than distribution. Its ₹5–8 crore first cheques and patient-capital stance make it a natural first call for deep-tech teams spinning out of labs — provided the IP story is real.